Staphylococcal Biofilms. Quest for the Magic Bullet.

Advances in Applied Microbiology

Volumn 81, Issue , 2012, Pages 63-87

  Brooks, Jamie L ^a   Jefferson, Kimberly K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antimicrobial agents; Biofilm; Device related infection; Staphylococci; Therapeutic approach

Indexed keywords

ALCOHOL; BMAP 28; CITRATE TRISODIUM; CITROPIN 1.1; CYCLIC DIGUANYL MONOPHOSPHATE; CYCLIC GMP DERIVATIVE; DORNASE ALFA; EDETIC ACID; ISEGANAN; LYSOSTAPHIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE K; TRYPSIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL IMMUNITY; BACTERICIDAL ACTIVITY; BIOFILM; CATHETER; CATHETER INFECTION; CELL COMMUNICATION; DRUG EFFICACY; HUMAN; MEDICAL DEVICE; MORBIDITY; MORTALITY; NONHUMAN; PHENOTYPE; PHOTODYNAMIC THERAPY; QUORUM SENSING; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS SIMULANS; UNSPECIFIED SIDE EFFECT; BACTERIUM ADHERENCE; GENETICS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

BACTERIAL ADHESION; BACTERIAL PROTEINS; BIOFILMS; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84865842308     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394382-8.00002-2     Document Type: Chapter

References (102)

1. Abraham N.M., Lamlertthon S., Fowler V.G., Jefferson K.K. Chelating agents exert distinct effects on biofilm formation in Staphylococcus aureus depending on strain background: role for Clumping factor B. Journal of Medical Microbiology 2012, 61:1062-1070.
2. Aguinaga A., Frances M.L., Del Pozo J.L., Alonso M., Serrera A., Lasa I., et al. Lysostaphin and clarithromycin: a promising combination for the eradication of Staphylococcus aureus biofilms. International Journal of Antimicrobial Agents 2011, 37:585-587.
3. Antoniani D., Bocci P., Maciag A., Raffaelli N., Landini P. Monitoring of diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors. Applied Microbiology and Biotechnology 2010, 85:1095-1104.
4. Balestrino D., Souweine B., Charbonnel N., Lautrette A., Aumeran C., Traore O., et al. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrology Dialysis Transplantation 2009, 24:3204-3209.
5. Barequet I.S., Bourla N., Pessach Y.N., Safrin M., Yankovich D., Ohman D.E., et al. Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis. Graefes Archive for Clinical and Experimental Ophthalmology 2012, 250:223-229.
6. Barequet I.S., Habot-Wilner Z., Mann O., Safrin M., Ohman D.E., Kessler E., et al. Evaluation of Pseudomonas aeruginosa staphylolysin (LasA protease) in the treatment of methicillin-resistant Staphylococcus aureus endophthalmitis in a rat model. Graefes Archive for Clinical and Experimental Ophthalmology 2009, 247:913-917.
7. Beenken K.E., Blevins J.S., Smeltzer M.S. Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infection and Immunity 2003, 71:4206-4211.
8. Beenken K.E., Mrak L.N., Griffin L.M., Zielinska A.K., Shaw L.N., Rice K.C., et al. Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS One 2010, 5:e10790.
9. Berger J., Diab-Elschahawi M., Blacky A., Pernicka E., Spertini V., Assadian O., et al. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance. American Journal of Infection Control 2010, 38:839-845.
10. Berrington A., Gould F.K. Use of antibiotic locks to treat colonized central venous catheters. Journal of Antimicrobial Chemotherapy 2001, 48:597-603.
11. Boles B.R., Horswill A.R. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathogens 2008, 4:e1000052.
12. Boles B.R., Horswill A.R. Staphylococcal biofilm disassembly. Trends in Microbiology 2011, 19:449-455.
13. Boles B.R., Thoendel M., Roth A.J., Horswill A.R. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 2010, 5:e10146.
14. Brindle E.R., Miller D.A., Stewart P.S. Hydrodynamic deformation and removal of Staphylococcus epidermidis biofilms treated with urea, chlorhexidine, iron chloride, or Dispersin B. Biotechnology and Bioengineering 2011, 108:2968-2977.
15. Broom J., Woods M., Allworth A., McCarthy J., Faoagali J., Macdonald S., et al. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scandinavian Journal of Infectious Disease 2008, 40:399-406.
16. Brouillette E., Hyodo M., Hayakawa Y., Karaolis D.K., Malouin F. 3',5'-cyclic diguanylic acid reduces the virulence of biofilm-forming Staphylococcus aureus strains in a mouse model of mastitis infection. Antimicrobial Agents and Chemotherapy 2005, 49:3109-3113.
17. Campos R.P., do Nascimento M.M., Chula D.C., Riella M.C. Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. Journal of the American Society of Nephrology 2011, 22:1939-1945.
18. Chaignon P., Sadovskaya I., Ragunah C., Ramasubbu N., Kaplan J.B., Jabbouri S. Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition. Applied Microbiology and Biotechnology 2007, 75:125-132.
19. Chambers S.T., Peddie B., Pithie A. Ethanol disinfection of plastic-adherent micro-organisms. Journal of Hospital Infection 2006, 63:193-196.
20. Cirioni O., Giacometti A., Ghiselli R., Bergnach C., Orlando F., Mocchegiani F., et al. Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Peptides 2006, 27:2104-2110.
21. Cirioni O., Giacometti A., Ghiselli R., Kamysz W., Orlando F., Mocchegiani F., et al. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides 2006, 27:1210-1216.
22. Crnich C., Maki D. Infections caused by intravascular devices: epidemiology, pathogenesis, diagnosis, prevention, and treatment. APIC text of infection control and epidemiology 2005, 24.21-24.26. Association for Professionals in Infection Control and Epidemiology, Washington, DC.
23. Crnich C.J., Halfmann J.A., Crone W.C., Maki D.G. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infection Control and Hospital Epidemiology 2005, 26:708-714.
24. Cue D., Lei M.G., Luong T.T., Kuechenmeister L., Dunman P.M., O'Donnell S., et al. Rbf promotes biofilm formation by Staphylococcus aureus via repression of icaR, a negative regulator of icaADBC. Journal of Bacteriology 2009, 191:6363-6373.
25. Dannenberg C., Bierbach U., Rothe A., Beer J., Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. Journal of Pediatric Hematology/Oncology 2003, 25:616-621.
26. Darouiche R.O., Mansouri M.D., Gawande P.V., Madhyastha S. Antimicrobial and antibiofilm efficacy of triclosan and Dispersin B combination. Journal of Antimicrobial Chemotherapy 2009, 64:88-93.
27. Di Poto A., Sbarra M.S., Provenza G., Visai L., Speziale P. The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms. Biomaterials 2009, 30:3158-3166.
28. Eckert R., He J., Yarbrough D.K., Qi F., Anderson M.H., Shi W. Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide. Antimicrobial Agents and Chemotherapy 2006, 50:3651-3657.
29. Eckert R., Qi F., Yarbrough D.K., He J., Anderson M.H., Shi W. Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Antimicrobial Agents and Chemotherpy 2006, 50:1480-1488.
30. Flemming K., Klingenberg C., Cavanagh J.P., Sletteng M., Stensen W., Svendsen J.S., et al. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. Journal of Antimicrobial Chemotherapy 2009, 63:136-145.
31. Fournier B., Hooper D.C. A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus. Journal of Bacteriology 2000, 182:3955-3964.
32. Frederiksen B., Pressler T., Hansen A., Koch C., Hoiby N. Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis. Acta Paediatrica 2006, 95:1070-1074.
33. Gandelman G., Frishman W.H., Wiese C., Green-Gastwirth V., Hong S., Aronow W.S., et al. Intravascular device infections: epidemiology, diagnosis, and management. Cardiology in Review 2007, 15:13-23.
34. Geisinger E., Muir T.W., Novick R.P. agr receptor mutants reveal distinct modes of inhibition by staphylococcal autoinducing peptides. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:1216-1221.
35. George E.A., Muir T.W. Molecular mechanisms of agr quorum sensing in virulent staphylococci. Chembiochem 2007, 8:847-855.
36. Ghiselli R., Giacometti A., Cirioni O., Mocchegiani F., Silvestri C., Orlando F., et al. Pretreatment with the protegrin IB-367 affects gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. Journal of Parenteral and Enteral Nutrition 2007, 31:463-468.
37. Hell E., Giske C.G., Nelson A., Romling U., Marchini G. Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Letters in Applied Microbiology 2010, 50:211-215.
38. Holland L.M., O'Donnell S.T., Ryjenkov D.A., Gomelsky L., Slater S.R., Fey P.D., et al. A staphylococcal GGDEF domain protein regulates biofilm formation independently of cyclic dimeric GMP. Journal of Bacteriology 2008, 190:5178-5189.
39. Ishihara Y., Hyodo M., Hayakawa Y., Kamegaya T., Yamada K., Okamoto A., et al. Effect of cyclic bis(3'-5')diguanylic acid and its analogs on bacterial biofilm formation. FEMS Microbiology Letters 2009, 301:193-200.
40. Itoh Y., Wang X., Hinnebusch B.J., Preston J.F., Romeo T. Depolymerization of beta-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. Journal of Bacteriology 2005, 187:382-387.
41. Izano E.A., Amarante M.A., Kher W.B., Kaplan J.B. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Applied and Environmental Microbiology 2008, 74:470-476.
42. Kaplan J.B., LoVetri K., Cardona S.T., Madhyastha S., Sadovskaya I., Jabbouri S., et al. Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci. The Journal of Antibiotics 2012, 65:73-77.
43. Karaolis D.K., Rashid M.H., Chythanya R., Luo W., Hyodo M., Hayakawa Y. c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation. Antimicrobial Agents and Chemotherapy 2005, 49:1029-1038.
44. Kashef N., Esmaeeli Djavid G., Siroosy M., Taghi Khani A., Hesami Zokai F., Fateh M. Photodynamic inactivation of drug-resistant bacteria isolated from diabetic foot ulcers. Iranian Journal of Microbiology 2011, 3:36-41.
45. Kharidia R., Liang J.F. The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms. Journal of Microbiology 2011, 49:663-668.
46. Knobloch J.K., Horstkotte M.A., Rohde H., Kaulfers P.M., Mack D. Alcoholic ingredients in skin disinfectants increase biofilm expression of Staphylococcus epidermidis. Journal of Antimicrobial Chemotherapy 2002, 49:683-687.
47. Kokai-Kun J.F., Chanturiya T., Mond J.J. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice. Journal of Antimicrobial Chemotherapy 2009, 64:94-100.
48. Kraus D., Peschel A. Molecular mechanisms of bacterial resistance to antimicrobial peptides. Current Topics in Microbiology and Immunology 2006, 306:231-250.
49. Lache M., Hearn W.R., Zyskind J.W., Tipper D.J., Strominger J.L. Specificity of a bacteriolytic enzyme from Pseudomonas aeruginosa. Journal of Bacteriology 1969, 100:254-259.
50. Lewis K. Riddle of biofilm resistance. Antimicrobial Agents and Chemotherapy 2001, 45:999-1007.
51. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry 2005, 70:267-274.
52. Li M., Cha D.J., Lai Y., Villaruz A.E., Sturdevant D.E., Otto M. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Molecular Microbiology 2007, 66:1136-1147.
53. Maki D.G., Kluger D.M., Crnich C.J. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proceedings 2006, 81:1159-1171.
54. Menousek J., Mishra B., Hanke M.L., Heim C.E., Kielian T., Wang G. Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300. International Journal of Antimicrobial Agents 2012, 39:402-406.
55. Mermel L.A., Allon M., Bouza E., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2009, 49:1-45.
56. Novick R.P., Geisinger E. Quorum sensing in staphylococci. Annual Review of Genetics 2008, 42:541-564.
57. O'Grady N.P., Alexander M., Burns L.A., Dellinger E.P., Garland J., Heard S.O., et al. Guidelines for the prevention of intravascular catheter-related infections. Clinical Infectious Diseases 2011, 52:e162-e193.
58. Onland W., Shin C.E., Fustar S., Rushing T., Wong W.Y. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Archives of Pediatrics and Adolescent Medicine 2006, 160:1049-1053.
59. Orsi G.B., Di Stefano L., Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infection Control and Hospital Epidemiology 2002, 23:190-197.
60. Otto M. Staphylococcus aureus and Staphylococcus epidermidis peptide pheromones produced by the accessory gene regulator agr system. Peptides 2001, 22:1603-1608.
61. Ozerdem Akpolat N., Elci S., Atmaca S., Akbayin H., Gul K. The effects of magnesium, calcium and EDTA on slime production by Staphylococcus epidermidis strains. Folia Microbiologica 2003, 48:649-653.
62. Pammi M., Liang R., Hicks J.M., Barrish J., Versalovic J. Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin. Pediatric Research 2011, 70:578-583.
63. Park J.H., Lee J.H., Kim C.J., Lee J.C., Cho M.H., Lee J. Extracellular protease in Actinomycetes culture supernatants inhibits and detaches Staphylococcus aureus biofilm formation. Biotechnology Letters 2012, 34:655-661.
64. Passerini L., Lam K., Costerton J.W., King E.G. Biofilms on indwelling vascular catheters. Critical Care Medicine 1992, 20:665-673.
65. Percival S.L., Kite P., Eastwood K., Murga R., Carr J., Arduino M.J., et al. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infection Control and Hospital Epidemiology 2005, 26:515-519.
66. Periasamy S., Joo H.S., Duong A.C., Bach T.H., Tan V.Y., Chatterjee S.S., et al. How Staphylococcus aureus biofilms develop their characteristic structure. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:1281-1286.
67. Peterson M.M., Mack J.L., Hall P.R., Alsup A.A., Alexander S.M., Sully E.K., et al. Apolipoprotein B is an innate barrier against invasive Staphylococcus aureus infection. Cell Host & Microbe 2008, 4:555-566.
68. Pierce D.A., Rocco M.V. Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells. Pharmacotherapy 2010, 30:1150-1158.
69. Qu Y., Istivan T.S., Daley A.J., Rouch D.A., Deighton M.A. Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. Journal of Medical Microbiology 2009, 58:442-450.
70. Raad I., Hanna H., Dvorak T., Chaiban G., Hachem R. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrobial Agents and Chemotherapy 2007, 51:78-83.
71. Raad I.I., Fang X., Keutgen X.M., Jiang Y., Sherertz R., Hachem R. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Current Opinion in Infectious Diseases 2008, 21:385-392.
72. Ramasubbu N., Thomas L.M., Ragunath C., Kaplan J.B. Structural analysis of dispersin B, a biofilm-releasing glycoside hydrolase from the periodontopathogen Actinobacillus actinomycetemcomitans. Journal of Molecular Biology 2005, 349:475-486.
73. Ramos E.R., Reitzel R., Jiang Y., Hachem R.Y., Chaftari A.M., Chemaly R.F., et al. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Critical Care Medicine 2010, 39:245-251.
74. Ravaioli S., Campoccia D., Visai L., Pirini V., Cangini I., Corazzari T., et al. Biofilm extracellular-DNA in 55 Staphylococcus epidermidis clinical isolates from implant infections. The International Journal of Artificial Organs 2011, 34:840-846.
75. Ribeiro A.P., Pavarina A.C., Dovigo L.N., Brunetti I.L., Bagnato V.S., Vergani C.E., et al. Phototoxic effect of curcumin on methicillin-resistant Staphylococcus aureus and L929 fibroblasts. Lasers in Medical Science 2012.
76. Saino E., Sbarra M.S., Arciola C.R., Scavone M., Bloise N., Nikolov P., et al. Photodynamic action of tri-meso (N-methyl-pyridyl), meso (N-tetradecyl-pyridyl) porphine on Staphylococcus epidermidis biofilms grown on Ti6Al4V alloy. International Journal of Artificial Organs 2010, 33:636-645.
77. Sandiford S., Upton M. Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci. Antimicrobial Agents and Chemotherapy 2012, 56:1539-1547.
78. Sauer K., Steczko J., Ash S.R. Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions. Journal of Antimicrobial Chemotherapy 2009, 63:937-945.
79. Sbarra M.S., Arciola C.R., Di Poto A., Saino E., Rohde H., Speziale P., et al. The photodynamic effect of tetra-substituted N-methyl-pyridyl-porphine combined with the action of vancomycin or host defense mechanisms disrupts Staphylococcus epidermidis biofilms. International Journal of Artificial Organs 2009, 32:574-583.
80. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochimica et Biophysica Acta 1999, 1462:55-70.
81. Shanks R.M., Meehl M.A., Brothers K.M., Martinez R.M., Donegan N.P., Graber M.L., et al. Genetic evidence for an alternative citrate-dependent biofilm formation pathway in Staphylococcus aureus that is dependent on fibronectin binding proteins and the GraRS two-component regulatory system. Infection and Immunity 2008, 76:2469-2477.
82. Shanks R.M., Sargent J.L., Martinez R.M., Graber M.L., O'Toole G.A. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrology Dialysis Transplantation 2006, 21:2247-2255.
83. Sharma M., Visai L., Bragheri F., Cristiani I., Gupta P.K., Speziale P. Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrobial Agents and Chemotherapy 2008, 52:299-305.
84. Sharma-Kuinkel B.K., Mann E.E., Ahn J.S., Kuechenmeister L.J., Dunman P.M., Bayles K.W. The Staphylococcus aureus LytSR two-component regulatory system affects biofilm formation. Journal of Bacteriology 2009, 191:4767-4775.
85. Skurnik D., Davis M.R., Benedetti D., Moravec K.L., Cywes-Bentley C., Roux D., et al. Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. Journal of Infectious Diseases 2012, 205:1709-1718.
86. Steczko J., Ash S.R., Nivens D.E., Brewer L., Winger R.K. Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens). Nephrology Dialysis Transplantation 2009, 24:1937-1945.
87. Tamayo R., Pratt J.T., Camilli A. Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annual Review of Microbiology 2007, 61:131-148.
88. Tetz G.V., Artemenko N.K., Tetz V.V. Effect of DNase and antibiotics on biofilm characteristics. Antimicrobial Agents and Chemotherapy 2009, 53:1204-1209.
89. Valle J., Toledo-Arana A., Berasain C., Ghigo J.M., Amorena B., Penades J.R., et al. SarA and not sigma(B) is essential for biofilm development by Staphylococcus aureus. Molecular Microbiology 2003, 48:1075-1087.
90. Venkatesh M., Rong L., Raad I., Versalovic J. Novel synergistic antibiofilm combinations for salvage of infected catheters. Journal of Medical Microbiology 2009, 58:936-944.
91. Vuong C., Gerke C., Somerville G.A., Fischer E.R., Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. Journal of Infectious Diseases 2003, 188:706-718.
92. Vuong C., Kocianova S., Voyich J.M., Yao Y., Fischer E.R., DeLeo F.R., et al. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. The Journal of Biological Chemistry 2004, 279:54881-54886.
93. Vuong C., Voyich J.M., Fischer E.R., Braughton K.R., Whitney A.R., DeLeo F.R., et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cellular Microbiology 2004, 6:269-275.
94. Walencka E., Sadowska B., Rozalska S., Hryniewicz W., Rozalska B. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin. Folia Microbiologica 2006, 51:381-386.
95. Walz J.M., Memtsoudis S.G., Heard S.O. Analytic reviews: prevention of central venous catheter bloodstream infections. Journal of Intensive Care Medicine 2010, 25:131-138.
96. Wang G., Li X., Wang Z. APD2: the updated Antimicrobial Peptide Database and its application in peptide design. Nucleic Acids Research 2009, 37:D933-D937.
97. Wang R., Khan B.A., Cheung G.Y., Bach T.H., Jameson-Lee M., Kong K.F., et al. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. The Journal of Clinical Investigation 2011, 121:238-248.
98. Wang X., Preston J.F., Romeo T. The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. Journal of Bacteriology 2004, 186:2724-2734.
99. Wu J.A., Kusuma C., Mond J.J., Kokai-Kun J.F. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrobial Agents and Chemotherapy 2003, 47:3407-3414.
100. Yarwood J.M., Bartels D.J., Volper E.M., Greenberg E.P. Quorum sensing in Staphylococcus aureus biofilms. Journal of Bacteriology 2004, 186:1838-1850.
101. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
102. Zhang R., Zhou M., Wang L., McGrath S., Chen T., Chen X., et al. Phylloseptin-1 (PSN-1) from Phyllomedusa sauvagei skin secretion: a novel broad-spectrum antimicrobial peptide with antibiofilm activity. Molecular Immunology 2010, 47:2030-2037.